advertisement
9.4.5.1 Neovascular glaucoma (16)
Showing records 1 to 16
Display all abstracts in classification 9.4.5.1 Neovascular glaucoma
Search within classification 9.4.5.1 Neovascular glaucoma25608 Electrophysiological evaluation and visual outcome in patients with central retinal vein occlusion, primary open-angle glaucoma and neovascular glaucoma
Wittstrom E; Ponjavic V; Lovestam-Adrian M; Larsson J; Andreasson S
Acta Ophthalmologica 2010; 88: 86-90
25237 Lysyl oxidase-like 1 gene polymorphisms in German patients with normal tension glaucoma, pigmentary glaucoma and exfoliation glaucoma
Wolf C; Gramer E; Müller-Myhsok B; Pasutto F; Gramer G; Wissinger B; Weisschuh N
Journal of Glaucoma 2010; 19: 136-141
25552 Clinical observation of panretinal photocoagulation, vitrectomy combined with pars plana Ahmed glaucoma valve implantation for neovascular glaucoma
Li S -H; Ye J; He X -G
International Journal of Ophthalmology 2009; 9: 1890-1891
25623 Anterior chamber bevacizumab for rubeotic glaucoma secondary to retinal artery occlusion
Bhojwani R; Kelly S P
Artery Research 2009; 3: 122-123
25566 Ahmed glaucoma valve implantation combined with anterior vitrectomy for treatment of neovascular glaucoma
Wang R -F; Li X; Gao X -W; Dong X -Y; Yang Z -Q; Yan X -D; Luo J
International Journal of Ophthalmology 2009; 9: 2332-2334
25470 Bevacizumab (Avastin(registered trademark)) for the management of anterior chamber neovascularization and neovascular glaucoma
Brouzas D; Charakidas A; Moschos M; Koutsandrea C; Apostolopoulos M; Baltatzis S
Clinical Ophthalmology 2009; 3: 685-688
25355 Changing causes of enucleation over the past 60 years
Setlur V J; Parikh J G; Rao N A
Graefe's Archive for Clinical and Experimental Ophthalmology 2009; 248: 593-597
25357 Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab
Lupinacci A P C; Calzada J I; Rafieetery M; Charles S; Netland P A
Advances in Therapy 2009; 26: 208-216
25592 Bevacizumab as adjuvant for neovascular glaucoma
Beutel J; Peters S; Luke M; Aisenbrey S; Szurman P; Spitzer M S; Yoeruek E; Grisanti S
Acta Ophthalmologica 2010; 88: 103-109
25422 Intravitreal bevacizumab for neovascular glaucoma
Vasudev D; Blair M P; Galasso J; Kapur R; Vajaranant T
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 453-458
25600 Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma
Saito Y; Higashide T; Takeda H; Ohkubo S; Sugiyama K
Acta Ophthalmologica 2010; 88: 96-102
25407 Concentration of vascular endothelial growth factor after intracameral bevacizumab injection in eyes with neovascular glaucoma.
Lim T H; Bae S H; Cho Y J; Lee J H; Kim H K; Sohn Y H
Korean Journal of Ophthalmology 2009; 23: 188-192
25404 Intravitreal bevacizumab for the treatment of neovascular glaucoma associated with central retinal artery occlusion.
Sagong M; Kim J; Chang W
Korean Journal of Ophthalmology 2009; 23: 215-218
25618 Intravitreal Bevacizumab in the treatment of neovascular glaucoma secondary to central retinal vein occlusion: A case report
Alasil T; Rauser M E
Cases Journal 2009; 2: 10: 176
25087 Anti-VEGF therapy for glaucoma
Horsley MB; Kahook MY
Current Opinions in Ophthalmology 2010; 21: 112-117
25581 Ahmed glaucoma valve implantation combined with retinal photocoagulation or cryocoagulation for the treatment of neovascular glaucoma
Tang G -X; Tian A -J; Wang X -B; Lu W -S; Zhou Y -Z; Lu J -H
International Journal of Ophthalmology 2009; 9: 2105-2107
